The nature of the mitogenic activity of pyrogenic streptococcal exotoxin B, also known as streptococcal cysteine protease, has been debated in the literature. streptococcal exotoxin B has been shown to cleave interleukin-1L precursor and create biologically active interleukin-1L, a major cytokine mediating inflammation and shock. This activity could mimic the mitogenicity and cytokine release induced by superantigens in lymphocyte stimulating experiments. In this study, the protease activity of streptococcal exotoxin B was irreversibly inhibited by covalent binding of a tripeptide and the superantigenic properties of streptococcal exotoxin B were found not to be influenced by this inactivation. Native as well as proteaseinactivated streptococcal exotoxin B was shown to stimulate T-cell proliferation without a need of metabolically active antigen presenting cells. Furthermore, streptococcal exotoxin B-induced T-cell proliferation was shown to require HLA-DQ since addition of HLA-DQ monoclonal antibodies totally inhibited the mitogenic activity of streptococcal exotoxin B, indicating that streptococcal exotoxin B, as other superantigens, makes direct contact with the T-cell receptor via HLA class II. The aim of this study was to characterize the relationship between the proteolytic and superantigenic properties of streptococcal exotoxin B. ß
Introduction
Numerous bacterial proteins have been identi¢ed as being superantigens (SAgs), e.g. in group A streptococci (GAS) and in Staphylococcus aureus, with an ability to induce massive proliferation of T-cells expressing particular VL elements [21, 34, 40] . These include the streptococcal pyrogenic exotoxins (Spes), SpeA, SpeB, SpeC, SpeF (MF), Ssa, SPM, SmeZ, and the recently discovered SmeZ2, SpeG, SpeH and SpeJ [1, 4, 15, 17, 26, 29, 32, 37, 47] . Peptides derived from the M-antigen (pep M5) have also been reported to have superantigenic activity [46, 48] .
Streptococcal SAg activity is due to their ability to activate T-cells and subsequent release of high amounts of cytokines believed to be major mediators in the pathogenesis of streptococcal toxic shock syndrome (STSS) [28, 34, 41] . Sera from patients with a severe streptococcal infection have been shown to have a signi¢cantly lower ability to neutralize SpeB and SpeF-induced T-cell mitogenicity than sera from patients with uncomplicated streptococcal infection [33] . Treatment of STSS with Q-globulin has been used [2] and it has also been reported that SAg-neutralizing antibodies are present in human Q-globulin, but the titers vary among di¡erent preparations [30, 31] .
Recently, several ¢ndings have indicated that many of the SAgs isolated from streptococci and staphylococci might also have catalytic functions. Crystallization studies have shown that SAg SpeC [23, 40] crystallizes as a dimer, which is a feature common among DNAses. The crystal structure of SEC2 revealed a zinc-binding motif resembling that present in zinc-dependent proteases such as tetanus toxin [27, 36] . The zinc-dependent homodimer of SED uses a lysine as one of the ligands, a rather unusual ligand, which has been observed in aminopeptidases [44, 45] . Furthermore, SpeF has been reported to have a heat resistant nuclease activity and was recently shown to be immunologically identical to DNAse B [6, 16] . However, the nuclease and superantigenic activities were found to involve separate domains of the protein [6] .
SpeB is also known as streptococcal cysteine protease and has been shown to contribute to virulence of GAS by several mechanisms [10, 11, 24, 35] . SpeB has shown to be able to release kinins [12] . Furthermore, SpeB also mediates the release of active interleukin (IL)-1L by cleavage of the IL-1L precursor and thereby directly in£uences the cytokine activity in tissue by a mechanism separate from the T-cellmediated response induced by SAgs [19] . SpeB was also shown to induce apoptosis in the monocyte U937 cell line through an IL-1L converting enzyme-dependent pathway [22] . Another virulence property mediated by the SpeB is the cleavage of human ¢bronectin and degradation of vitronectin, which might accelerate invasion of the bacteria and contribute to the necrotizing activity of GAS [20] . Due to these additional activities of SpeB, some authors claim that the proposed superantigenic properties of SpeB actually are derived from its proteolytic activities [38] .
The aim of this study was to characterize the relationship between the proteolytic and superantigenic properties of SpeB.
Materials and methods

Protein puri¢cation
Streptococcal strain T10BW, known to be a high producer of SpeB, was cultured in antigen-free medium at 37³C overnight [13] . The supernatant was recovered by centrifugation at 4400Ug for 30 min, following sterile ¢ltration. Protein was precipitated with 65% saturation of ammonium sulfate at 4³C overnight and collected by centrifugation at 4400Ug for 30 min. The protein precipitate was dissolved in dH 2 O, concentrated and desalted to 1.2 mS cm 31 over 10 000 NMWL low binding regenerated cellulose ¢lters between minitan plates (Millipore, Bedford, MA, USA). The protein concentrate was ethanol-precipitated with 75% ethanol (99.5%) at 370³C for 24 h. The precipitate was diluted in dH 2 O, prior to application in a Rotofor1 preparative isoelectric focusing cell (Bio-Rad, Stockholm, Sweden) for separation by pI. Fractions that reacted with a rabbit anti-SpeB antisera in a Western blot were pooled, followed by immunoprecipitation of remaining SpeF in the protein suspension using CnBr-coupled anti-SpeF-Sepharose. All protein suspensions were tested for the endotoxin content using Limulus Amoebocyte Lysate (Chromogenics, Go « teborg, Sweden) before they were used in proliferation experiments.
Inhibition of protease activity
Puri¢ed SpeB (120 Wg) was activated at 40³C in 100 Wl activation bu¡er (0.1 M NaAc, 5 WM EDTA, 10 mM DTT, pH 5.5). After 20 min activation, the tripeptide Z-LVG-CHN 2 [3] was added to a ¢nal concentration of 20 WM. The peptide blocking of the SpeB active site was allowed to proceed for 30 min to accomplish complete inactivation of the protolytic activity as described [3] . The inactivated protein was concentrated and washed with 0.05 M Tris-HCl, 0.25 M NaCl, pH 8.4, over a 10-kDa ¢lter (Millipore, Stockholm, Sweden). Proteinase activity was measured as below.
Protease activity
Protease activity of SpeB and inactivated SpeB was measured by azocasein cleavage. Puri¢ed SpeB, 1.5 Wg, was incubated at 40³C in 100 Wl activation bu¡er as above. After 30 min, an equal volume of 2% azocasein (Sigma, St. Louis, MO, USA) in 3 M urea was added and cleavage was allowed to proceed for an additional 30 min before precipitation of uncleaved azocasein with 500 Wl 3% trichloroacetic acid (TCA). The precipitate was removed by centrifugation and the A 366 of the supernatant was measured. Blanks were prepared by immediately precipitating 100 Wl of the reaction solution with 500 Wl 3% TCA.
Preparation of peripheral blood mononuclear cells (PBMCs) and cell culture conditions
Human PBMCs were recovered over Lymphoprep gradients (Nycomed, Oslo, Norway). T-cells were separated from puri¢ed PBMCs by erythrocyte-rosetting [19] followed by overnight adherence to plastic. The erythrocyte-rosette negative cells were used as antigen presenting cells (APCs) [18] . For proliferation assays, PBMCs (3U10 5 
Blocking of HLA-DQ class II molecules
PBMCs were recovered over the Lymphoprep gradient (Nycomed) as described above and immediately pre-incubated for 15 min at room temperature with 0.1 Wg ml 31 anti-human class II-DQ antiserum (Bu46) (The Binding Site, Birmingham, UK). The pre-incubated PBMCs were then submitted to stimulation in vitro at 3U10 5 PBMCs per well with SpeB or inactivated SpeB, 5 ng ml 31 in microtiter plates for 72 h. Cell growth was measured by incorporation of [ 3 H]thymidine as described above.
Paraformaldehyde (PFA) ¢xation of APCs
Erythrocyte-rosette negative cells puri¢ed as described above were ¢xed with 0.5% PFA (w/v) for 15 min at room temperature. Immediately after incubation, eight volumes of 0.15 M glycine, pH 7.2, were added, the cells were washed once with glycine bu¡er. The cells were further incubated for 30 min at 37³C, 5% humidity, in RPMI 1640 (Gibco BRL) supplemented with 2 mM L-glutamine (Gibco BRL), 100 Wg ml 31 gentamicin (Sigma) and 10% fetal calf serum (KEBO Lab AB, Stockholm, Sweden). The cells were washed three times in HBSS and resuspended in culture media before use as APCs as described. Indomethacin, 1 Wg ml 31 (Sigma), was added to PBMCs (5U10 6 cells ml 31 ) in a 5-ml cul- ) was incubated at 40³C in 100 Wl acidic bu¡er (pH 5.5) for 30 min before addition of equal volumes of 2% azocasein in 3 M urea. After 30 min, uncleaved azocasein was precipitated by addition of 500 Wl TCA (3%) and the A 366 was determined in a spectrophotometer. As a negative control, 500 Wl TCA was added to 40³C acidic bu¡er immediately after addition of 2% azocasein in 3 M urea.
ture £ask and incubated overnight at 37³C, 5% humidity, to obtain IL-1-and IL-6-enriched conditioned media as described previously [33] . PFA-¢xed APCs were stimulated with 5 ng ml 31 SpeB or protease-inactivated SpeB together with 50 Wl cell-free IL-1-and IL-6-conditioned media per well for 3 days. Cell growth was measured for 6 h at day 4 as above. Cells were also stimulated with 10 Wg ml 31 PPD for 6 days and lack of proliferation demonstrated that the ¢xation procedure worked.
Results
Purity and protease activity
The puri¢ed protein yielded a single 28-kDa band on SDS-PAGE by silver staining that did not react with SpeA, SpeC and SpeF polyclonal antisera in Western blot analysis. Furthermore, one portion of the puri¢ed SpeB was irreversible protease-inactivated by addition of tripeptide Z-NVG-CHN 2 under acidic conditions (pH 5.5). The inactivation procedure of SpeB using the tripeptide was tested using a spectrophotometric assay at A 366 , where the treated SpeB preparation was found to be unable to cleave azocasein (Fig. 1) . SpeB and inactivated SpeB were equally recognized by a rabbit polyclonal antisera raised against SpeB in a Western blot analysis as well as in an enzyme-linked immunosorbent assay (ELISA) (data not shown).
Mitogenicity of SpeB and protease-inactivated SpeB
In a lymphocyte proliferation assay where the amount of SpeB used was titrated from 100 ng ml 31 down to 0.1 ng ml 31 , both the native and protease-inhibited SpeB preparation showed lymphocyte stimulating activity at the lowest concentration (Fig.  2) . That is comparable to other well-known SAgs. The mitogenic activity of SpeB and inactivated SpeB at a concentration of 5 ng ml 31 was almost completely inhibited by addition of 0.1 Wg ml 31 anti-HLA-DQ monoclonal antibodies in a proliferation assay as compared to the lymphocyte prolifer- ation with untreated PBMCs (Fig. 3) . This indicates that SpeB require HLA-DQ for activity and that SpeB, in the same way as other known streptococcal SAgs (SpeF and SpeA), preferentially binds to HLA-DQ [14, 15, 33] . These results are supported by previous ¢ndings that SpeB binds very weakly to HLA-DP and not so well to HLA-DR but has a good a¤nity to HLA-DQ [15] .
SpeB and inactivated SpeB do not require active APCs for activation of T-lymphocyte proliferation
In two separate proliferation experiments, SpeB was able to stimulate T-cell proliferation to cpm values above 10 000 when paraformaldehyde-¢xated APCs were used. These values correspond to 333 5% of the [ 3 H]thymidine incorporation determined when untreated APCs were used in lymphocyte proliferation experiments stimulating with SpeB and inactivated SpeB (Fig. 4) . This is to be compared to a 48% reduction in T-lymphocyte proliferation when SpeA was used, analyzed under the same conditions. This demonstrates that SpeB-induced mitogenicity does not require processing by APCs. However, in all experiments, the level of T-cell proliferation induced by SpeB was about 50% compared to that induced by SpeA or SEB at the same concentrations and in the same experiment.
Discussion
SpeB is a protease and as such might induce events, such as cytokine release, that mimics the SAg-induced T-cell stimulation. In this report, we have inactivated the protease activity by addition of a tripeptide that irreversibly inhibits the protease activity as determined by its inability to cleave azocasein (Fig. 1) . However, SpeB lacking protease activity was still recognized by polyclonal antisera raised against the native protein in both ELISA and SDS-PAGE, which indicated that the structure of the protein was comparable to that of the native protein. Despite the inability of the tripeptide-treated SpeB to act as a protease, it was as e¡ective as the native SpeB when applied in a proliferation assay. The T-cell proliferation was almost completely blocked by addition of HLA-DQ antibodies, indicating that SpeB requires HLA-DQ for mitogenicity, which would not be the case if the mitogenic activity was related to release of active IL-1L after SpeB cleavage of IL-1L precursor. The protein was able to induce proliferation even when PFA-¢xed APCs were used, although with addition of IL-1 and IL-6-conditioned media since the induced proliferation might be reduced when using metabolically inactive APCs [32] . This again is a prerequisite for the de¢-nition of a SAg. SAgs have been shown not to require processing prior to presentation, rather, the intact SAgs make contact with the MHC molecule outside the peptide-binding groove. So far, the superantigenic properties of SpeB cannot be explained by its protease activities.
The streptococcal SAgs are all rather similar in size and pI and at least SpeB and SpeF are produced by most of the GAS isolates. In some studies, it has been reported that mitogenic activity of SpeB was only noted when Wg amounts of the protein were added to lymphocytes. Furthermore, some authors claim that they have separated the VL8 stimulation both from SpeB and pep M5 puri¢cations [5, 8, 9, 38, 42] . If Wg amounts were required for mitogenicity, a contaminant undetectable on a SDS-PAGE could be present in ng amounts, a concentration at which SAgs have been shown to induce T-cell stimulation [7, 32, 34] . In this report, that explanation can be excluded, since the puri¢ed SpeB protein used was active at a concentration of 0.1 ng ml 31 and only one homogenous band could be detected on a silver-stained SDS-PAGE. Furthermore, rabbit polyclonal antisera raised against SpeF or SpeC, the most similar streptococcal SAgs in terms of molecular mass and pI, in a Western blot, did not recognize our SpeB protein preparation. Thus, a contaminant with superantigenic activity would only be present below pg amounts under the experimental conditions used (5 ng SpeB ml 31 ). No such an active SAg has to our knowledge been reported.
The homogeneity of a protein preparation can be assured only if it is produced from a de¢ned gene, cloned into a host de¢cient of similar products, but this technique also involves di¤culties. The host must be able to fold the protein properly, transport it over the membrane and allow formation of S-Sbridges and so on. One argument for excluding SpeB from the SAg family has been that recombinant SpeB protein expressed in Escherichia coli was found to lack mitogenic activity [5, 7, 8, 9, 47] . However, other investigators have found recombinant SpeB expressed in E. coli to have VL8 mitogenic activity comparable to that of the native protein [4, 21] . In another report, it was shown that the post-translational modi¢cation of Ssa was di¡erent when produced in E. coli compared to native protein from GAS and a¡ected Ssa both in terms of the protease sensitivity and VL speci¢city. This indicated that caution has to be taken when recombinant SAgs are studied [43] . In a recent report by Lyon et al. [25] , SpeB was shown to require production of RopA, a chaperone homologous to trigger factor from Bacillus subtilis. RopA was shown to in£uence secretion and post-translational modi¢cations of SpeB. The requirement for such a chaperone protein, possibly not present in E. coli, to assure accurate folding of the protein could perhaps explain the inconsistency in the reports concerning the mitogenic activity of di¡erent recombinant SpeB preparations. This problem might be resolved by cloning RN 4220 devoid of other SAgs but perhaps more similar to GAS into a host such as S. aureus [39] .
Conclusion
In summary, we report that SpeB puri¢ed from Streptococcus pyogenes was shown to behave as a SAg. SpeB-induced T-cell stimulation requires HLA-DQ but not processing by APCs prior to presentation and it was active at ng concentrations. Furthermore, as reported for streptococcal SAg SpeF whose SAg activity is independent of the DNAse activity, the catalytic function, i.e. the protease activity of SpeB, was shown to have no in£uence on the mitogenicity of the protein.
